ZIMMER BIOMET HOLDINGS, INC. (ZBH) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Win; Revenue growth Win; EPS growth Lose.
36/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 3 wins, 9 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseZBH / S&P -4.54% / 15.20% |
LoseZBH / S&P 8.62% / 15.00% |
LoseZBH / S&P 0.49% / 50.40% |
| 2026-Q11/3 |
WinZBH / S&P 0.83% / -4.33% |
LoseZBH / S&P 9.23% / 11.30% |
LoseZBH / S&P -14.41% / 27.70% |
| 2025-Q40/3 |
LoseZBH / S&P -8.47% / 2.65% |
LoseZBH / S&P 7.20% / 9.00% |
LoseZBH / S&P -20.05% / 13.40% |
| 2025-Q32/3 |
WinZBH / S&P 8.26% / 8.12% |
WinZBH / S&P 5.47% / 4.61% |
LoseZBH / S&P -23.24% / 13.45% |
| 2025-Q20/3 |
LoseZBH / S&P -19.20% / 10.94% |
LoseZBH / S&P 4.11% / 4.83% |
LoseZBH / S&P -14.41% / 10.63% |
| 2025-Q11/3 |
WinZBH / S&P 7.38% / -4.27% |
LoseZBH / S&P 3.30% / 4.98% |
LoseZBH / S&P -2.17% / 10.57% |
| 2024-Q40/3 |
LoseZBH / S&P -1.93% / 2.41% |
LoseZBH / S&P 3.84% / 5.25% |
LoseZBH / S&P -9.02% / 6.15% |
| 2024-Q31/3 |
LoseZBH / S&P -0.31% / 5.89% |
LoseZBH / S&P 4.34% / 5.89% |
WinZBH / S&P 132.30% / 6.11% |
| 2024-Q21/3 |
LoseZBH / S&P -17.59% / 4.28% |
LoseZBH / S&P 4.58% / 5.38% |
WinZBH / S&P 98.76% / 5.12% |
| 2024-Q11/3 |
LoseZBH / S&P 8.65% / 10.56% |
LoseZBH / S&P 4.85% / 5.71% |
WinZBH / S&P 115.42% / 5.59% |
| 2023-Q41/3 |
LoseZBH / S&P 8.66% / 11.69% |
LoseZBH / S&P 6.55% / 6.81% |
WinZBH / S&P 343.64% / 7.78% |
| 2023-Q31/3 |
LoseZBH / S&P -22.76% / -3.27% |
LoseZBH / S&P 5.62% / 7.52% |
WinZBH / S&P 71.21% / -5.03% |
| 2023-Q22/3 |
WinZBH / S&P 12.88% / 8.74% |
LoseZBH / S&P 4.17% / 9.50% |
WinZBH / S&P 121.10% / -8.57% |
| 2023-Q11/3 |
LoseZBH / S&P 1.53% / 7.50% |
LoseZBH / S&P 3.17% / 10.77% |
WinZBH / S&P 107.77% / -15.69% |
| 2022-Q41/3 |
WinZBH / S&P 22.18% / 7.56% |
LoseZBH / S&P 1.65% / 11.88% |
LoseZBH / S&P -42.11% / -17.99% |
| 2022-Q31/3 |
WinZBH / S&P -0.26% / -4.88% |
LoseZBH / S&P 10.48% / 13.47% |
LoseZBH / S&P -66.33% / -1.41% |
| 2022-Q20/3 |
LoseZBH / S&P -17.67% / -16.10% |
LoseZBH / S&P 6.56% / 13.71% |
LoseZBH / S&P -75.17% / 11.04% |
| 2022-Q11/3 |
WinZBH / S&P 3.90% / -4.60% |
LoseZBH / S&P 15.88% / 15.97% |
LoseZBH / S&P -62.13% / 42.23% |
| 2021-Q40/3 |
LoseZBH / S&P -13.04% / 11.03% |
LoseZBH / S&P 11.42% / 15.00% |
LoseZBH / S&P -379.41% / 96.40% |
| 2021-Q30/3 |
LoseZBH / S&P -8.85% / 0.58% |
LoseZBH / S&P -11.70% / 10.77% |
LoseZBH / S&P -615.79% / 69.42% |
| 2021-Q21/3 |
LoseZBH / S&P 0.61% / 8.55% |
LoseZBH / S&P -7.76% / 6.58% |
WinZBH / S&P 2643.75% / 51.81% |
| 2021-Q11/3 |
LoseZBH / S&P 4.05% / 6.17% |
LoseZBH / S&P -23.69% / -1.06% |
WinZBH / S&P 50.28% / 7.39% |
| 2020-Q41/3 |
WinZBH / S&P 13.37% / 12.15% |
LoseZBH / S&P -23.24% / -3.72% |
LoseZBH / S&P -112.43% / -33.42% |
| 2020-Q32/3 |
WinZBH / S&P 14.26% / 8.93% |
LoseZBH / S&P -10.88% / -2.04% |
WinZBH / S&P 58.33% / -27.10% |
| 2020-Q20/3 |
LoseZBH / S&P 18.33% / 20.54% |
LoseZBH / S&P -10.72% / -0.46% |
LoseZBH / S&P -109.04% / -27.11% |
| 2020-Q10/3 |
LoseZBH / S&P -32.30% / -19.60% |
LoseZBH / S&P -1.27% / 3.47% |
LoseZBH / S&P -219.08% / -14.75% |
| 2019-Q41/3 |
WinZBH / S&P 9.21% / 9.07% |
LoseZBH / S&P 0.62% / 5.36% |
LoseZBH / S&P -392.51% / 2.99% |
| 2019-Q31/3 |
WinZBH / S&P 16.79% / 1.70% |
LoseZBH / S&P -0.03% / 5.02% |
LoseZBH / S&P -105.59% / 0.21% |
| 2019-Q20/3 |
LoseZBH / S&P -7.61% / 4.30% |
LoseZBH / S&P -0.44% / 6.64% |
LoseZBH / S&P -121.40% / 8.65% |
| 2019-Q11/3 |
WinZBH / S&P 23.35% / 13.65% |
LoseZBH / S&P ZBH unavailable / 8.12% |
LoseZBH / S&P -118.38% / 14.29% |
| 2018-Q40/3 |
LoseZBH / S&P -20.92% / -13.52% |
LoseZBH / S&P ZBH unavailable / 9.05% |
LoseZBH / S&P -121.03% / 18.23% |
| 2018-Q32/3 |
WinZBH / S&P 18.19% / 7.71% |
LoseZBH / S&P ZBH unavailable / 10.21% |
WinZBH / S&P 168.97% / 19.06% |
| 2018-Q21/3 |
LoseZBH / S&P 2.42% / 3.43% |
LoseZBH / S&P ZBH unavailable / 9.03% |
WinZBH / S&P 136.96% / 14.46% |
| 2018-Q11/3 |
LoseZBH / S&P -9.44% / -0.76% |
LoseZBH / S&P ZBH unavailable / 7.68% |
WinZBH / S&P 240.33% / 12.46% |
| 2017-Q41/3 |
LoseZBH / S&P 3.26% / 6.64% |
LoseZBH / S&P ZBH unavailable / 7.03% |
WinZBH / S&P 492.67% / 13.82% |
| 2017-Q31/3 |
LoseZBH / S&P -8.62% / 4.48% |
LoseZBH / S&P ZBH unavailable / 5.68% |
WinZBH / S&P 75.27% / 17.57% |
| 2017-Q22/3 |
WinZBH / S&P 5.35% / 3.09% |
LoseZBH / S&P ZBH unavailable / 4.83% |
WinZBH / S&P 203.48% / 17.74% |
| 2017-Q12/3 |
WinZBH / S&P 18.56% / 6.07% |
LoseZBH / S&P ZBH unavailable / 3.67% |
WinZBH / S&P 683.87% / 13.32% |
| 2016-Q41/3 |
LoseZBH / S&P -20.44% / 3.82% |
LoseZBH / S&P ZBH unavailable / 2.09% |
WinZBH / S&P 97.37% / 7.05% |
| 2016-Q32/3 |
WinZBH / S&P 8.22% / 3.85% |
LoseZBH / S&P ZBH unavailable / 0.20% |
WinZBH / S&P 82.00% / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | ZBH total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -5.25% | 20.78% |
| Annualized return | -5.25% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | ZBH total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -29.08% | 83.14% |
| Annualized return | -6.64% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | ZBH total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -13.32% | 319.30% |
| Annualized return | -1.42% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |